Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5QZL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,368
Award facts
- Contract value 100% obligated
- $20,368.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,368.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pens on January 16, 2026, with completion targeted for January 20, 2026. This non-set-aside competitive award represents a single task order drawn against AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location, supplying the immunosuppressant medication to support federal military healthcare programs.
This delivery order exemplifies the operational scope of Cencora's comprehensive pharmaceutical prime vendor contract with DLA, which covers specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains for military treatment facilities and other federal healthcare systems worldwide. AmerisourceBergen has demonstrated sustained capability to fulfill federal medical procurement requirements through its extensive portfolio of competitively awarded contracts, ranging from small-value transactions to substantial orders exceeding $45,000, positioning it as a critical vendor within the federal medical supply chain serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DR26F5QZL?
SPE2DR26F5QZL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F5QZL worth?
The government has obligated $20,368 on SPE2DR26F5QZL.
Is contract SPE2DR26F5QZL an order under another contract?
Yes. SPE2DR26F5QZL is a delivery order under SPE2DR25D2013, an indefinite delivery contract.
Was contract SPE2DR26F5QZL competed?
The extent of competition for SPE2DR26F5QZL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award